EUS-guided Ethanol-lipiodol Ablation of Pancreatic Neuroendocrine Tumor: a Prospective Study

NAUnknownINTERVENTIONAL
Enrollment

34

Participants

Timeline

Start Date

July 31, 2013

Primary Completion Date

June 30, 2017

Study Completion Date

August 31, 2017

Conditions
EfficacySafetyFeasibility
Interventions
PROCEDURE

EUS-guided ethanol-lipiodol mixture ablation

By using 3D-volumetric analysis, the optimal volume of ethanol/lipiodol (1:1 mixture) is calculated by computer estimation of areas on each axial image, using EUS software permitting volume calculation. After calculating optimal ethanol volume by 3D volumetric analysis, we advance the needle into the tumor and inject estimated volume of ethanol, typically 1 to 1.5 ml.

Trial Locations (1)

138-736

Asan Medical Center, Seoul

Sponsors
All Listed Sponsors
collaborator

Dankook University

OTHER

lead

Asan Medical Center

OTHER

NCT01902238 - EUS-guided Ethanol-lipiodol Ablation of Pancreatic Neuroendocrine Tumor: a Prospective Study | Biotech Hunter | Biotech Hunter